Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures

Combined antiretroviral therapy (cART) has greatly decreased mortality and morbidity among persons with HIV; however, neurologic impairments remain prevalent, in particular HIV-associated neurocognitive disorders (HANDs). White matter damage persists in cART-treated persons with HIV and may contribu...

Full description

Bibliographic Details
Main Authors: Hubert Monnerie, Micah Romer, Lindsay M. Roth, Caela Long, John S. Millar, Kelly L. Jordan-Sciutto, Judith B. Grinspan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnmol.2023.1323431/full
_version_ 1797397509387059200
author Hubert Monnerie
Micah Romer
Lindsay M. Roth
Caela Long
John S. Millar
Kelly L. Jordan-Sciutto
Judith B. Grinspan
author_facet Hubert Monnerie
Micah Romer
Lindsay M. Roth
Caela Long
John S. Millar
Kelly L. Jordan-Sciutto
Judith B. Grinspan
author_sort Hubert Monnerie
collection DOAJ
description Combined antiretroviral therapy (cART) has greatly decreased mortality and morbidity among persons with HIV; however, neurologic impairments remain prevalent, in particular HIV-associated neurocognitive disorders (HANDs). White matter damage persists in cART-treated persons with HIV and may contribute to neurocognitive dysfunction as the lipid-rich myelin membrane of oligodendrocytes is essential for efficient nerve conduction. Because of the importance of lipids to proper myelination, we examined the regulation of lipid synthesis in oligodendrocyte cultures exposed to the integrase strand transfer inhibitor elvitegravir (EVG), which is administered to persons with HIV as part of their initial regimen. We show that protein levels of genes involved in the fatty acid pathway were reduced, which correlated with greatly diminished de novo levels of fatty acid synthesis. In addition, major regulators of cellular lipid metabolism, the sterol regulatory element-binding proteins (SREBP) 1 and 2, were strikingly altered following exposure to EVG. Impaired oligodendrocyte differentiation manifested as a marked reduction in mature oligodendrocytes. Interestingly, most of these deleterious effects could be prevented by adding serum albumin, a clinically approved neuroprotectant. These new findings, together with our previous study, strengthen the possibility that antiretroviral therapy, at least partially through lipid dysregulation, may contribute to the persistence of white matter changes observed in persons with HIV and that some antiretrovirals may be preferable as life-long therapy.
first_indexed 2024-03-09T01:12:06Z
format Article
id doaj.art-d47bdc2e2ecf4e7fa6028db6e43612a6
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-03-09T01:12:06Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-d47bdc2e2ecf4e7fa6028db6e43612a62023-12-11T04:28:43ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992023-12-011610.3389/fnmol.2023.13234311323431Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte culturesHubert Monnerie0Micah Romer1Lindsay M. Roth2Caela Long3John S. Millar4Kelly L. Jordan-Sciutto5Judith B. Grinspan6Department of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDepartment of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDepartment of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDepartment of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesInstitute of Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Pathology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesCombined antiretroviral therapy (cART) has greatly decreased mortality and morbidity among persons with HIV; however, neurologic impairments remain prevalent, in particular HIV-associated neurocognitive disorders (HANDs). White matter damage persists in cART-treated persons with HIV and may contribute to neurocognitive dysfunction as the lipid-rich myelin membrane of oligodendrocytes is essential for efficient nerve conduction. Because of the importance of lipids to proper myelination, we examined the regulation of lipid synthesis in oligodendrocyte cultures exposed to the integrase strand transfer inhibitor elvitegravir (EVG), which is administered to persons with HIV as part of their initial regimen. We show that protein levels of genes involved in the fatty acid pathway were reduced, which correlated with greatly diminished de novo levels of fatty acid synthesis. In addition, major regulators of cellular lipid metabolism, the sterol regulatory element-binding proteins (SREBP) 1 and 2, were strikingly altered following exposure to EVG. Impaired oligodendrocyte differentiation manifested as a marked reduction in mature oligodendrocytes. Interestingly, most of these deleterious effects could be prevented by adding serum albumin, a clinically approved neuroprotectant. These new findings, together with our previous study, strengthen the possibility that antiretroviral therapy, at least partially through lipid dysregulation, may contribute to the persistence of white matter changes observed in persons with HIV and that some antiretrovirals may be preferable as life-long therapy.https://www.frontiersin.org/articles/10.3389/fnmol.2023.1323431/fullcARTHandHIVmyelinoligodendrocyteSREBP
spellingShingle Hubert Monnerie
Micah Romer
Lindsay M. Roth
Caela Long
John S. Millar
Kelly L. Jordan-Sciutto
Judith B. Grinspan
Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures
Frontiers in Molecular Neuroscience
cART
Hand
HIV
myelin
oligodendrocyte
SREBP
title Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures
title_full Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures
title_fullStr Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures
title_full_unstemmed Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures
title_short Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures
title_sort inhibition of lipid synthesis by the hiv integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures
topic cART
Hand
HIV
myelin
oligodendrocyte
SREBP
url https://www.frontiersin.org/articles/10.3389/fnmol.2023.1323431/full
work_keys_str_mv AT hubertmonnerie inhibitionoflipidsynthesisbythehivintegrasestrandtransferinhibitorelvitegravirinprimaryratoligodendrocytecultures
AT micahromer inhibitionoflipidsynthesisbythehivintegrasestrandtransferinhibitorelvitegravirinprimaryratoligodendrocytecultures
AT lindsaymroth inhibitionoflipidsynthesisbythehivintegrasestrandtransferinhibitorelvitegravirinprimaryratoligodendrocytecultures
AT caelalong inhibitionoflipidsynthesisbythehivintegrasestrandtransferinhibitorelvitegravirinprimaryratoligodendrocytecultures
AT johnsmillar inhibitionoflipidsynthesisbythehivintegrasestrandtransferinhibitorelvitegravirinprimaryratoligodendrocytecultures
AT kellyljordansciutto inhibitionoflipidsynthesisbythehivintegrasestrandtransferinhibitorelvitegravirinprimaryratoligodendrocytecultures
AT judithbgrinspan inhibitionoflipidsynthesisbythehivintegrasestrandtransferinhibitorelvitegravirinprimaryratoligodendrocytecultures